Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹26,835.18Admitted-Finance 1003 1005 VISHAL TOWER DISTRICT CENTRE JANAK PURI NEW DELHI DELHI 110058 | WEST DELHI | DELHI | 110058 | L1 | Admitted-Finance | |
| 2 | L2₹31,068.87+₹4,233.69 (15.8%)Admitted-Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | L2 | Admitted-Finance | |
| 3 | Rejected-Technical 45 MOTI BUNGALOW DEWAS MADHYA PRADESH 455001 | DEWAS | MADHYA PRADESH | 455001 | - | Rejected-Technical AS PER TECH |
| Sl No | Description | Qty | Unit | SMPL Life Sciences Pvt. Ltd. L1 | Medikon India Private Limited L2 |
|---|---|---|---|---|---|
| 1.00Dept of RHEUMATOLOGY | |||||
| 1.01 | Tocilizumab 20mg/ml 10ml Inj | 180 | VIAL | 14,200 ₹14,910 Lowest | - |
| 2.01 | Tocilizumab 80mg Inj /4ml | 240 | VIAL | 6,482.65 ₹6,806.78 Lowest | - |
| 3.01 | Cross Linked sodium hyaluronic acid hylan 6mDa,8mg/ml 6ml PFS | 261 | PFS | 4,570 ₹5,118.4 Lowest | - |
| 4.01 | Herpes Zoster Vaccine recombinant adjuvanted | 240 | No | - | 8,799 ₹9,238.95 Lowest |
| 5.01 | Inj Ixekizumab 80mg/ml | 120 | PFS/Vial | - | 19,491 ₹21,829.92 Lowest |
Tender Value
₹1.3 Cr
EMD Value
₹6.5 L
Closing Date
30 Sept 2024, 6:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
433/D-354,314/RHEUMATOLOGY/IFA RE-124/2024-25 FOR AHRR
2024_ARMY_673378_1
433/D-354,314/RHEUMATOLOGY/IFA RE-124/2024-25
Open Tender
Medical Equipments/Waste
Buy
30 days
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹6.5 L
Yes
11 Nov 2024
9 Sept 2024
1 Oct 2024
9 Sept 2024
30 Sept 2024
9 Sept 2024
9 Sept 2024 - 30 Sept 2024
Dept of RHEUMATOLOGY
Tocilizumab 20mg/ml 10ml Inj
Tocilizumab 80mg Inj /4ml
Cross Linked sodium hyaluronic acid hylan 6mDa,8mg/ml 6ml PFS
Herpes Zoster Vaccine recombinant adjuvanted
Inj Ixekizumab 80mg/ml
Medikon India Private Limited (BID ID -3116128)
SMPL Life Sciences Pvt. Ltd.
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.39 MB
RFP.pdf
Tender Documents • 1.33 MB
BOQ_752863.xls
BOQ • 0.30 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .